[Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)]

Chinese Society of Hepatology, Chinese Medical Association,Chinese Society of Infectious Diseases, Chinese Medical Association
DOI: https://doi.org/10.3760/cma.j.cn501113-20221204-00607
2022-12-20
Abstract:In order to update the prevention, diagnosis and treatment of chronic hepatitis B, and to achieve the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by World Health Organization, Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association, organized experts in 2022 to update and the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). Under the idea of more extensive screening, more active prevention and antiviral treatment, we provide latest evidence and recommendations in the prevention, diagnosis and treatment of chronic hepatitis B in China.
What problem does this paper attempt to address?